Vericel (VCEL) Competitors

Vericel (NASDAQ:VCEL) and Qiagen (NYSE:QGEN) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings, dividends and community ranking.

Does the media refer more to VCEL or QGEN?

In the previous week, Vericel had 7 more articles in the media than Qiagen. MarketBeat recorded 11 mentions for Vericel and 4 mentions for Qiagen. Vericel's average media sentiment score of 1.54 beat Qiagen's score of 0.26 indicating that Vericel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vericel	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Qiagen	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders believe in VCEL or QGEN?

70.0% of Qiagen shares are held by institutional investors. 5.2% of Vericel shares are held by company insiders. Comparatively, 9.0% of Qiagen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has stronger earnings & valuation, VCEL or QGEN?

Qiagen has higher revenue and earnings than Vericel. Qiagen is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vericel	$237.22M	9.74	-$3.18M	$0.18	255.94
Qiagen	$1.98B	4.45	$83.59M	$0.36	110.14

Which has more risk & volatility, VCEL or QGEN?

Vericel has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500. Comparatively, Qiagen has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500.

Does the MarketBeat Community believe in VCEL or QGEN?

Vericel received 105 more outperform votes than Qiagen when rated by MarketBeat users. Likewise, 61.78% of users gave Vericel an outperform vote while only 60.29% of users gave Qiagen an outperform vote.

Company	Underperform	Outperform
Vericel	Outperform Votes 354 61.78%	Underperform Votes 219 38.22%
Qiagen	Outperform Votes 249 60.29%	Underperform Votes 164 39.71%

Do analysts prefer VCEL or QGEN?

Vericel currently has a consensus target price of $62.29, suggesting a potential upside of 35.20%. Qiagen has a consensus target price of $47.71, suggesting a potential upside of 20.32%. Given Vericel's stronger consensus rating and higher possible upside, equities analysts plainly believe Vericel is more favorable than Qiagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vericel	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00
Qiagen	0 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.30

Is VCEL or QGEN more profitable?

Qiagen has a net margin of 4.23% compared to Vericel's net margin of 1.56%. Qiagen's return on equity of 13.92% beat Vericel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vericel	1.56%	1.48%	0.96%
Qiagen	4.23%	13.92%	8.40%

Summary

Vericel beats Qiagen on 10 of the 18 factors compared between the two stocks.